The attempts to use anti-TGF-β-based therapies for metastatic pancreatic ductal adenocarcinoma demonstrate the importance of understanding the role of TGFβ in pancreatic cancer progression [65]. The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.